KALA News and Press, Kala Pharmaceuticals Inc. From 11/15/21

Kala Pharmaceuticals (NASDAQ:KALA): Q3 GAAP EPS of -$0.43 in-line. Revenue of $3.1M (+39.6% Y/Y) misses by $2.06M. Press Release As of September 30, 2021, Kala had cash and cash equivalents of $124.5M, compared to $149.6M of cash, cash equivalents and short-term investments as of June 30, 202...

-- Achieved $3.1 Million in Net Revenue in 3Q 2021 -- -- EYSUVIS® Prescriptions Increased by 19% Compared to 2Q 2021 -- Expanding Clinical-Stage Pipeline Through Acquisition of Combangio -- -- Conference Call and Webcast at 10:30 a.m. ET -- WATERTOWN, Mass...

-- KPI-012 is a novel secretome with a multifactorial mechanism of action for development in PCED and other orphan ocular surface diseases driven by impaired corneal healing -- -- KPI-012 demonstrated positive safety and efficacy results in PCED Phase 1b clinical trial -- -- K...

WATERTOWN, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it has changed the tim...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Kala Pharmaceuticals (NASDAQ:KALA) is scheduled to announce Q3 earnings results on Monday, November 15th, before market open. The consensus EPS Estimate is -$0.42 and the consensus Revenue Estimate is $5.16M (+132.4% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward revision and ...

ACM, ACRX, ADN, AMPY, AVPT, AYRO, BCLI, BFLY, CLSN, OTCQB:CVSI, FREY, GMDA, GOED, KALA, MICT, OEG, ONDS, OTLY, PLX, PTN, RAIL, SOHU, TLS, TRVN, TSN, VBLT For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open

WATERTOWN, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will partic...

WATERTOWN, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report third q...

If you’re like most traders in the stock market today, you’re on the hunt for the best penny stocks to buy now. Heading into the remainder of the week, there are plenty of different trends to follow. Following this week’s FOMC meeting, many expect a Santa Claus rally go...